These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Metrifonate treatment enhances acquisition of eyeblink conditioning in aging rabbits. Kronforst-Collins MA; Moriearty PL; Ralph M; Becker RE; Schmidt B; Thompson LT; Disterhoft JF Pharmacol Biochem Behav; 1997 Jan; 56(1):103-10. PubMed ID: 8981616 [TBL] [Abstract][Full Text] [Related]
3. Nicotinic modulation in an animal model of a form of associative learning impaired in Alzheimer's disease. Woodruff-Pak DS; Santos IS Behav Brain Res; 2000 Aug; 113(1-2):11-9. PubMed ID: 10942028 [TBL] [Abstract][Full Text] [Related]
4. Metrifonate increases neuronal excitability in CA1 pyramidal neurons from both young and aging rabbit hippocampus. Oh MM; Power JM; Thompson LT; Moriearty PL; Disterhoft JF J Neurosci; 1999 Mar; 19(5):1814-23. PubMed ID: 10024365 [TBL] [Abstract][Full Text] [Related]
5. Effect of subchronic treatment with metrifonate and tacrine on brain cholinergic function in aged F344 rats. Giovannini MG; Scali C; Bartolini L; Schmidt B; Pepeu G Eur J Pharmacol; 1998 Jul; 354(1):17-24. PubMed ID: 9726626 [TBL] [Abstract][Full Text] [Related]
6. Cholinergic facilitation of trace eyeblink conditioning in aging rabbits. Disterhoft JF; Kronforst-Collins M; Oh MM; Power JM; Preston AR; Weiss C Life Sci; 1999; 64(6-7):541-8. PubMed ID: 10069521 [TBL] [Abstract][Full Text] [Related]
8. Age-related deficits in the retention of memories for cued fear conditioning are reversed by galantamine treatment. Gould TJ; Feiro OR Behav Brain Res; 2005 Dec; 165(2):160-71. PubMed ID: 16154210 [TBL] [Abstract][Full Text] [Related]
9. Modulation of cholinergic transmission enhances excitability of hippocampal pyramidal neurons and ameliorates learning impairments in aging animals. Disterhoft JF; Matthew Oh M Neurobiol Learn Mem; 2003 Nov; 80(3):223-33. PubMed ID: 14521865 [TBL] [Abstract][Full Text] [Related]
11. Effects of subchronic administration of metrifonate on cholinergic neurotransmission in rats. Hinz VC; Kolb J; Schmidt BH Neurochem Res; 1998 Jul; 23(7):931-8. PubMed ID: 9690734 [TBL] [Abstract][Full Text] [Related]
12. Pharmacological and molecular enhancement of learning in aging and Alzheimer's disease. Disterhoft JF; Oh MM J Physiol Paris; 2006; 99(2-3):180-92. PubMed ID: 16458491 [TBL] [Abstract][Full Text] [Related]
13. Nefiracetam ameliorates associative learning impairment in the scopolamine-injected older rabbit. Pak J; Green J; Heifets B; Pak M; Woodruff-Pak D Med Sci Monit; 2002 Apr; 8(4):BR105-12. PubMed ID: 11951055 [TBL] [Abstract][Full Text] [Related]
14. Effects of metrifonate, its transformation product dichlorvos, and other organophosphorus and reference cholinesterase inhibitors on Morris water escape behavior in young-adult rats. van der Staay FJ; Hinz VC; Schmidt BH J Pharmacol Exp Ther; 1996 Aug; 278(2):697-708. PubMed ID: 8768721 [TBL] [Abstract][Full Text] [Related]
15. The effect of food and time of administration on the pharmacokinetic and pharmacodynamic profile of metrifonate. Heinig R; Sachse R Int J Clin Pharmacol Ther; 1999 Sep; 37(9):456-64. PubMed ID: 10507245 [TBL] [Abstract][Full Text] [Related]
16. The recovery of cerebrospinal fluid acetylcholinesterase activity in Alzheimer's disease patients after treatment with metrifonate. Unni L; Vicari S; Moriearty P; Schaefer F; Becker R Methods Find Exp Clin Pharmacol; 2000; 22(1):57-61. PubMed ID: 10791297 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics, pharmacodynamics, and safety of metrifonate in patients with Alzheimer's disease. Pettigrew LC; Bieber F; Lettieri J; Wermeling DP; Schmitt FA; Tikhtman AJ; Ashford JW; Smith CD; Wekstein DR; Markesbery WR; Orazem J; Ruzicka BB; Mas J; Gulanski B J Clin Pharmacol; 1998 Mar; 38(3):236-45. PubMed ID: 9549662 [TBL] [Abstract][Full Text] [Related]
18. The effects of metrifonate on the cognitive, behavioral, and functional performance of Alzheimer's disease patients. Metrifonate Study Group. Raskind MA; Cyrus PA; Ruzicka BB; Gulanski BI J Clin Psychiatry; 1999 May; 60(5):318-25. PubMed ID: 10362441 [TBL] [Abstract][Full Text] [Related]
19. Metrifonate decreases sI(AHP) in CA1 pyramidal neurons in vitro. Power JM; Oh MM; Disterhoft JF J Neurophysiol; 2001 Jan; 85(1):319-22. PubMed ID: 11152731 [TBL] [Abstract][Full Text] [Related]
20. Galantamine: effect on nicotinic receptor binding, acetylcholinesterase inhibition, and learning. Woodruff-Pak DS; Vogel RW; Wenk GL Proc Natl Acad Sci U S A; 2001 Feb; 98(4):2089-94. PubMed ID: 11172080 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]